CONTENTS:
- Misuse of gabapentin and pregabalin: a marker for a more serious malaise? [Editorial]. Stannard C., p. 1699-1700.
- Tampering of opioid analgesics: a serious challenge for public health? [Editorial]. Kimergard A., Breindahl T., Hindersson P., Deluca P., p. 1701-1702.
- Extent of alcohol prohibition in civil policy in Muslim majority countries: the impact of globalization [For debate]. Al-Ansari B., Thow A.-M., Day C.A., Conigrave K.M., p. 1703-1713.
- What should national alcohol control policies in Muslim majority countries focus on? Bahelah R., p. 1714-1715.
- Influence of Islam and the globalized alcohol industry on drinking in Muslim countries. Assanangkornchai S., Talek M., Edwards J.G., p. 1715-1716.
- The role of religion in alcohol consumption and demand reduction in Muslim majority countries (MMC). Kalema D., Vanderplasschen W., Vindevogel S., Derluyn I., p. 1716-1718.
- Civil alcohol policy in Muslim majority countries: need for global tools, expert support and local partnerships. Al-Ansari B., Day C.A., Thow A.-M., Conigrave K.M., p. 1718-1719.
- Questioning the validity of the 4+/5+ binge or heavy drinking criterion in college and clinical populations [For debate]. Pearson M.R., Kirouac M., Witkiewitz K., p. 1720-1726.
- Better options than self-report of consumption. Andreasson S., p. 1727-1728.
- Settling the score: moving beyond the 5/4 criterion debate. Wells S., De Wit D.J., Elton-Marshall T., p. 1728-1729.
- One size should not fit all, so use the right tool for the job. Carey K.B., Miller M.B., p. 1729-1731.
- Questions about the validity of the binge or heavy drinking criterion have implications for more than just treatment evaluation. Havard A., p. 1731-1732.
- Human cognition tips the balance away from thresholds. Moore S.C., p. 1732-1733.
- We still question the utility and validity of the binge/heavy drinking criterion. Pearson M.R., Kirouac M., Witkiewitz K., p. 1733-1734.
- Gender differences in the impact of population-level alcohol policy interventions: evidence synthesis of systematic reviews. Fitzgerald N., Angus K., Emslie C., Shipton D., Bauld L., p. 1735-1747.
- Commentary on Fitzgerald et al. (2016): Gender differences in the impact of population-level policy interventions will depend upon what you measure. Connor J., p. 1748-1749.
- Smoking in movies and smoking initiation in adolescents: systematic review and meta-analysis. Leonardi-Bee J., Nderi M., Britton J., p. 1750-1763.
- Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Hall W., Lynskey M., p. 1764-1773.
- European longitudinal study on the relationship between adolescents' alcohol marketing exposure and alcohol use. de Bruijn A., Tanghe J., de Leeuw R., Engels R., Anderson P., Beccaria F., et al., p. 1774-1783.
- Commentary on de Bruijn et al. (2016): Effective alcohol marketing policymaking requires more than evidence on alcohol marketing effect - research on vested interest effects is needed. O'Brien K.S., Carr S.M., p. 1784-1785.
- The burden of alcohol use disorders in US military veterans: results from the National Health and Resilience in Veterans Study. Fuehrlein B.S., Mota N., Arias A.J., Trevisan L.A., Kachadourian L.K., Krystal J.H., et al., p. 1786-1794.
- Parental alcohol-related disorders and school performance in 16-year-olds - a Swedish national cohort study. Berg L., Bäck K., Vinnerljung B., Hjern A., p. 1795-1803.
- Commentary on Berg et al. (2016): Who's minding the children - do we need to focus on reducing intergenerational risk due to parents who drink problematically? Kaner E., McGovern R., p. 1804-1805.
- Alcohol-attributed disease burden in four Nordic countries: a comparison using the Global Burden of Disease, Injuries and Risk Factors 2013 study. Agardh E.E., Danielsson A.-K., Ramstedt M., Ledgaard Holm A., Diderichsen F., Juel K., et al., p. 1806-1813.
- Cognitive ability and risk for substance misuse in men: genetic and environmental correlations in a longitudinal nation-wide family study. Latvala A., Kuja-Halkola R., D'Onofrio B.M., Larsson H., Lichtenstein P., p. 1814-1822.
- Commentary on Latvala et al. (2016): What can genetic cognitive epidemiology tell us about substance misuse and addiction? Luciano M., p. 1823-1824.
- Alcohol and marijuana use trajectories in a diverse longitudinal sample of adolescents: examining use patterns from age 11 to 17 years. D'Amico E.J., Tucker J.S., Miles J.N.V., Ewing B.A., Shih R.A., Pedersen E.R., p. 1825-1835.
- Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Amin-Esmaeili M., Rahimi-Movaghar A., Sharifi V., Hajebi A., Radgoodarzi R., Mojtabai R., et al., p. 1836-1847.
- The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre. Cairns R., Brown J.A., Buckley N.A., p. 1848-1853.
- Commentary on Cairns et al. (2016): Over-the-counter codeine in Australia - questioning the efficacy of current restrictions or re-scheduling. McDonough M., p. 1854-1855.
- From cannabis initiation to daily use: educational inequalities in consumption behaviours over three generations in France. Legleye S., Khlat M., Mayet A., Beck F., Falissard B., Chau N., et al., p. 1856-1866.
- Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men. Vogel T., Dom G., van de Glind G., Studer J., Gmel G., Strik W., et al., p. 1867-1878.
- Comments on Strang et al. (2016): 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'. Doe-Simkins M., Banta-Green C., Davis C.S., Green T.C., Walley A.Y., p. 1879-1880.
- While we dither, people continue to die from overdose: Comments on 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'. Coffin P., Rich J., Dailey M., Stancliff S., Beletsky L., p. 1880-1881.
- Letters to Addiction from Coffin et al. and Doe-Simpkins et al. re: 'For Debate' on clinical use of improvised nasal naloxone sprays: authors' response. Strang J., McDonald R., p. 1881-1883.